Edition:
United Kingdom

Neurotrope Inc (NTRP.OQ)

NTRP.OQ on NASDAQ Stock Exchange Capital Market

7.19USD
16 Jan 2018
Change (% chg)

$0.21 (+3.01%)
Prev Close
$6.98
Open
$7.10
Day's High
$7.59
Day's Low
$7.00
Volume
8,060
Avg. Vol
7,939
52-wk High
$21.31
52-wk Low
$3.41

Latest Key Developments (Source: Significant Developments)

Neurotrope Appoints Charles S. Ryan As CEO
Monday, 18 Dec 2017 

Dec 18 (Reuters) - Neurotrope Inc ::NEUROTROPE APPOINTS CHARLES S. RYAN AS CHIEF EXECUTIVE OFFICER.NEUROTROPE INC - ‍ APPOINTMENT OF CHARLES RYAN FOLLOWS RESIGNATION OF SUSANNE WILKE, PHD, AS CHIEF EXECUTIVE OFFICER AND DIRECTOR​.NEUROTROPE INC - RYAN BECOMES A DIRECTOR OF COMPANY EFFECTIVE IMMEDIATELY AND WILL ASSUME HIS RESPONSIBILITIES AS CEO EFFECTIVE FEBRUARY 15, 2018.  Full Article

BRIEF-Neurotrope's Bryostatin Improves Cognition In Patients

* NEUROTROPE'S BRYOSTATIN IMPROVES COGNITION IN PATIENTS WITH ADVANCED ALZHEIMER'S DISEASE BASED ON FURTHER ANALYSIS OF PHASE 2 CLINICAL TRIAL DATA Source text for Eikon: Further company coverage: